A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo - Wikidata - awgldk - TriplyDB

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

http://www.wikidata.org/entity/Q36023093

about

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo DNA immunization as a technology platform for monoclonal antibody induction The role of Fc-FcγR interactions in IgG-mediated microbial neutralization Influenza virus hemagglutinin stalk-based antibodies and vaccines Cell-targeting antibodies in immunity to Ebola Replication-competent fluorescent-expressing influenza B virus Universal influenza virus vaccines and therapeutic antibodies.Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice Novel universal influenza virus vaccine approaches Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.Reconstruction of the 1918 influenza virus: unexpected rewards from the past 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.Animal models for influenza viruses: implications for universal vaccine development Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.Replication-competent influenza A viruses expressing a red fluorescent protein.Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination.Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

P2860

Q24568302-70A21F57-F528-4A47-BB90-30B04573CD93 Q26751432-438DD4C8-DD38-446E-8677-E5882327C623 Q26797466-3D4339E4-F974-41BF-8F37-B0662F4C2693 Q27001190-925A633F-476D-46F6-92F3-C24902C3830E Q28068972-1587B489-B575-4B8B-9B4D-8621D5494CC0 Q28387786-22364235-1D3C-4AFD-AF6D-5365CC333A11 Q30151337-3595C027-2DB6-4572-89D7-DFA156E1824C Q30207889-013CDB60-58DC-4AED-A6E7-251718622B7E Q30223058-F39189E4-15B7-4FCB-B393-81BB9137EA16 Q30355516-F111FA55-FB8F-4199-8C79-D2D8D2A0888E Q30357665-E23E85B0-C764-417D-9590-9B30E53A8E7D Q30366045-D15395DF-48BA-48C9-999F-D422AE8315F5 Q30370793-F91D98BF-1353-43AC-8911-626A54BA00BD Q30372274-31DB6BDE-EFE2-4DA2-B751-7676D212BF02 Q30374373-FA1C8F68-A33B-4A2A-AB37-29B686CEF530 Q30375314-0A5028F4-8DE7-4B2D-899E-331E936ACD38 Q30376724-A57183BB-1F24-4838-A3E3-D4ACC415025A Q30380785-97EE488E-71C9-45FA-A539-36DD6996CED6 Q30385071-F8942C4E-E5F3-4DA0-9E7E-592EEA8E1743 Q30387031-1D65BED6-E401-4B08-8D76-6292C903F226 Q30393724-FA5924E4-8A5C-46AC-98BD-D1EF93E89EA2 Q30419085-CC1B9188-C1A5-4ACE-AB23-C711E4DFC2D7 Q30421157-5B46826A-A5A1-47B2-80BE-ED55A22731D9 Q30422641-58C0E1A2-8638-4C76-9BD7-D0DF1F1162D2 Q30430923-CF1456FF-F2F0-46A8-ABB1-8A6111F9EF5B Q34395834-8E3E64FA-4CBE-4500-861F-6F4532F80D2F Q34511080-30324FD6-F93D-4925-A628-9A2E767EC32E Q34594065-401718E8-D300-4CD6-8C02-480F217A146B Q34809686-BF2E09CA-823B-4D33-9BEC-7C4AD278B518 Q34976021-18A54190-3EDF-47F5-AFAE-F858DD5D91E5 Q35071285-FAA14A17-3E75-4608-B404-356536D96F16 Q35756765-4276463C-13DF-47EF-9D26-8EAAFF266D6A Q35990859-3C860D3A-96C4-413C-AF5B-F963653009C9 Q36434265-5B81CDF0-9660-44B0-BDF0-52CA74915388 Q36482776-1FDE7022-9D2F-40F8-ACFC-4197E151F410 Q36496580-168750A7-C45B-4476-8B2C-E11637D3DCAC Q36727656-1E5B286B-961C-47F8-AB4C-3EDDBA18A2C6 Q36760064-A6944164-DC55-4532-948B-4503E0B43125 Q36911722-D4C95101-5391-4DD3-B72B-5B5B9CBD1F66 Q36991414-1A2B2CD7-D65E-4B3F-8DB8-8ECF7A42DC8C

P2860

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

http://www.wikidata.org/entity/Q36023093

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@ast

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@en

type

label

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@ast

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@en

prefLabel

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@ast

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@en

P1433

Q36023093-FF5C2864-B5AD-4A5B-957D-C92E4F868D6C

P1476

Q36023093-A65A65B4-AC97-49FE-9C01-BB9FF0334EB6

P2093

Q36023093-3A84AF18-E13C-43D2-86DD-62E6852ACE30

Q36023093-A0B838EF-1F76-44DD-A7F2-4A772365481C

Q36023093-CE4C2400-3155-4280-BDCE-E63509F9D778

P2860

Q36023093-19E8EF71-7A34-45A8-B9C0-5B82A8531C7E

Q36023093-1A01F168-0E1D-4290-BE7B-D8A543928418

Q36023093-1DC43CDE-3EC9-4CD3-8960-EFC3AFCD998A

Q36023093-1FFE8DF6-4DF2-4459-9EA0-0961B6EEE233

Q36023093-200FED3F-E4A6-48B3-B8E1-6C0B9F164D8B

Q36023093-21DBE315-A1DC-464F-97EA-40A2A1D4827B

Q36023093-2C8CF0C9-BBA2-4088-9E59-CAD9386B25F2

Q36023093-2CD6F89D-2414-409D-B800-C5AB30D6D733

Q36023093-49675BD5-C66D-4657-82C0-95DE939BFFCA

Q36023093-4FD0B3F9-08DF-4D12-AD39-A85378CA4B88

P304

Q36023093-715298D2-0CEA-4074-A1D3-58EB848BF82D

P31

Q36023093-B968A959-1276-44AC-9F9F-DAFD57483502

P356

Q36023093-50C8F678-DC6E-4F56-803A-50117C32A1FB

P407

Q36023093-59163344-5882-4A10-BF94-F57301653092

P433

Q36023093-4C321F8F-F1AC-4C22-AD13-7625621F65EC

P478

Q36023093-93E14F42-1EC6-428D-B5AD-7A60305433AA

P50

Q36023093-5D911DB9-BC3A-4ED6-8094-0B3ACD86894D

Q36023093-634668FF-9D9D-46A9-9088-305F08C9EF58

Q36023093-D91B9E7A-4850-4B2F-B938-01059030C265

P577

Q36023093-E8D5316C-AB27-4D83-964C-E31A4FABEB1D

P698

Q36023093-FDA9F2AF-6D8D-4ADE-A0C4-857EDC92F14B

P921

Q36023093-37AC8C16-5F26-41C8-AF34-B97C36FDBC70

P932

Q36023093-056493F6-E31F-46DB-83AB-0A3C617300E8

P356

P1433

Journal of Virology

P1476

A pan-H1 anti-hemagglutinin mo ...... road-spectrum efficacy in vivo

@en

P2093

Alita Kongchanagul

http://www.w3.org/2001/XMLSchema#string

Dirk Eggink

http://www.w3.org/2001/XMLSchema#string

Thomas M Moran

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Current and future antiviral therapy of severe seasonal and avian influenza

Viral membrane fusion

N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

P304

6179-6188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00469-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Florian Krammer

P577

2012-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22491456

http://www.w3.org/2001/XMLSchema#string

P921

P932

3372189

http://www.w3.org/2001/XMLSchema#string